Melissa Russ

Melissa Russ has extensive work experience in the biopharmaceutical industry. Currently, they hold the position of Director - Development Business Operations at Equillium, Inc. Prior to this, they worked as a Consultant - Clinical Contracts and Budgets at Principia Biopharma and as a Sr. Manager - Contracts at NGM Biopharmaceuticals. Melissa also held roles at Dynavax Technologies, Juno Therapeutics, Gilead Sciences, Genentech, Cato Research, Cato BioVentures, and Hilton Worldwide. In these positions, they gained expertise in areas such as clinical contracts, budgets, finance, business development, and project coordination. Overall, Melissa has a strong background in the biopharmaceutical industry, with a focus on business operations and contracts.

Melissa Russ completed their Bachelor of Science degree in Biology at Tufts University from 1997 to 2001. Melissa then pursued a Master of Science degree in Environmental Toxicology at the University of Wollongong from 2003 to 2006. In 2006-2007, Melissa Russ engaged in continuing education in Law at UCLA. Additionally, they participated in a continuing education program at Harvard University in 2002, although the field of study is not specified.